azacitidine

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

azacitidine
Aug 14, 2024, 07:20 | Drugs
Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax
Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…
Aug 10, 2024, 01:18 | Blog
JAMA Oncology Review: The Latest Treatment Options for Acute Myeloid Leukemia by Sylvester Comprehensive Cancer Center
Recently approved drugs are rapidly changing the treatment of patients with acute myeloid leukemia (AML),…
Jul 13, 2024, 19:41 | Insight
Joshua Zeidner: Subset analyses from QUAZAR study
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about a recent paper by…
Jul 9, 2024, 00:57 | Insight
Talha Badar: Outcome after stopping venetoclax and azacitidine
Talha Badar shared on X: “American Journal of Hematology, Blood Research Journal, Wiley Online Library.…
Jun 19, 2024, 07:28 | Insight
Naval Daver presents findings of the ENHANCE-3 study at EHA2024 - AML Hub
AML Hub shared the following post on X:    . "CONGRESS EHA2024 | Naval Daver…
Jun 18, 2024, 14:51 | Insight
Amer Zeidan: Our newest paper on 61 TP53-mutated AML
Amer Zeidan shared on X: "Our newest paper with a detailed Integrated analysis of genetic,…
Jun 2, 2024, 22:16 | Insight
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…
Apr 5, 2024, 08:22 | Insight
Hagop Kantarjian: Low-dose azacitidine plus venetoclax - in patients with AML unable to complete standard consolidation strategies
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Jan 5, 2024, 17:36 | Insight
Talha Badar: What is the right duration of Venetoclax with HMA for AML?
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, shared on X/Twitter:…
Jul 7, 2023, 09:51 | Opinion
How I do venetoclax+azacitidine induction AML - Aaron Goodman
How I do venetoclax+azacitidine induction AML Ven 400 mg* days 1-28+aza 75mg/m2 days 1-7 BMBx…
All: 10 Posts: 1 - 100
Special Coverage